Nursing care
Hemochromatosis nursing care: what to assess and what to do first
Written and reviewed by Dana Whitfield, RN, MSN · 5 min read · Updated September 2026
Short answer
Hemochromatosis is a genetic disorder causing excessive iron absorption and storage, treated by regularly removing blood through phlebotomy to reduce iron levels. Left untreated, it progresses to a late triad of bronze-coloured skin, diabetes and cirrhosis. Early detection and lifelong treatment adherence prevent this irreversible organ damage.
What it is and why it happens
Hereditary hemochromatosis is caused most commonly by mutations in the HFE gene, which disrupts normal regulation of iron absorption in the small intestine. Instead of absorbing only what the body needs, patients absorb excess iron continuously over years, and because the body has no efficient way to excrete iron, it accumulates progressively in the liver, heart, pancreas, joints and skin.
The disease is typically inherited in an autosomal recessive pattern, meaning symptomatic disease usually requires two copies of the mutated gene, though carriers with one copy can have mildly elevated iron studies. Onset is gradual, often not producing symptoms until middle age, which is why family history and incidental abnormal iron studies are frequently how the diagnosis is first suspected rather than presenting symptoms alone.
How it presents — what you will actually see
Early hemochromatosis is often silent or produces only vague fatigue, joint pain, particularly in the second and third knuckles, and mild abdominal discomfort from liver involvement. Because these symptoms overlap with so many common conditions, the diagnosis is frequently delayed for years after symptoms begin.
As iron accumulation progresses, the late-stage picture becomes distinctive: bronze or grey discolouration of the skin from iron deposition and increased melanin, diabetes mellitus from iron damage to the pancreas, and cirrhosis from long-standing hepatic iron overload. This combination has historically been called bronze diabetes, and recognising it as a single disease process rather than three unrelated findings is the key clinical insight.
Nursing assessment priorities
Ask specifically about joint pain, fatigue, and change in libido or erectile function, since hemochromatosis can cause hypogonadism through pituitary iron deposition and patients rarely volunteer this. Inspect the skin for a bronze or greyish tint, particularly in sun-exposed areas, and compare against the patient's baseline colouring or old photographs when family reports a change.
Review liver function tests, fasting blood glucose, and cardiac symptoms at every visit, since the heart, liver and pancreas are the organs most vulnerable to iron toxicity. Family history is a critical assessment point given the genetic inheritance pattern; ask about first-degree relatives with liver disease, diabetes, or early cardiac disease of unclear cause.
Interventions and what to do first
Therapeutic phlebotomy is the primary treatment and the intervention that defines nursing care for this disease. Removing a unit of blood weekly or every other week during the induction phase draws down iron stores because the body uses stored iron to replace the lost red blood cells. Frequency decreases to a maintenance schedule, often every two to four months, once ferritin reaches target levels.
Monitor serum ferritin and transferrin saturation to guide phlebotomy frequency and confirm the treatment is working. For patients who cannot tolerate phlebotomy, iron chelation therapy is an alternative, though it is less effective and reserved for that circumstance. Reinforce that phlebotomy is lifelong maintenance, not a course of treatment with an endpoint.
Complications to watch for
Cirrhosis is the complication with the highest stakes, since it is irreversible once established and significantly raises the risk of hepatocellular carcinoma, meaning patients with existing cirrhosis need ongoing liver cancer screening even after iron levels are controlled. Cardiac involvement can produce cardiomyopathy and arrhythmias from iron deposition in heart muscle, sometimes presenting as heart failure in a relatively young patient.
Diabetes from pancreatic iron damage may require the same ongoing management as any other diabetes diagnosis and does not necessarily improve once iron levels normalise if pancreatic damage has already occurred. Joint damage from iron deposition in synovial tissue can also become a chronic pain source independent of iron control, so early treatment before organ damage sets in matters more than treatment intensity later.
Patient teaching before discharge
Emphasise that phlebotomy is a lifelong commitment, not a temporary treatment, and that missed sessions allow iron to reaccumulate. Explain the rationale clearly: removing blood forces the body to use stored iron to make new red cells, which is why it works even though the intervention itself sounds unrelated to iron.
Advise limiting alcohol intake strictly, since alcohol accelerates liver damage on top of existing iron toxicity, and discourage iron and vitamin C supplements, since vitamin C increases iron absorption. Encourage first-degree relatives to be screened with iron studies given the genetic inheritance, and stress that early treatment before organ damage occurs can prevent the bronze skin, diabetes and cirrhosis that define untreated disease.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our med-surg practice questions are the closest set to what this page covers.
One question from the med-surg set
A client with chronic obstructive pulmonary disease has an oxygen saturation of 88% on 2 L/min via nasal cannula and is alert with no distress. What should the nurse do first?
Rationale
In COPD a saturation of 88–92% is the therapeutic target, not an emergency, and this client is alert with no distress. The first action is the independent nursing intervention that is least invasive and most likely to help: sit them up and reassess. Turning the oxygen up to 6 L/min risks blunting the hypoxic drive, and calling rapid response or drawing an ABG escalates ahead of an assessment you have not finished.
Answer: B
Common questions
Why does removing blood treat an iron overload disease?
Phlebotomy works because removing red blood cells forces the bone marrow to make new ones, and the body draws on its excess stored iron to build the haemoglobin those new cells need. Over repeated sessions this steadily depletes total body iron stores, which is why it remains first-line treatment despite sounding unrelated to the underlying problem.
What causes the bronze skin colour in hemochromatosis?
Iron deposits directly in the skin and also stimulate increased melanin production, together producing a bronze or greyish discolouration, most visible in sun-exposed areas. It typically appears only after years of untreated iron accumulation and signals advanced disease.
Is hemochromatosis reversible with treatment?
Iron levels and many symptoms improve significantly with regular phlebotomy, and life expectancy can be normal if treatment starts before organ damage occurs. However, established cirrhosis and existing diabetes from pancreatic damage typically do not reverse, which is why early diagnosis matters more than treatment intensity once damage has occurred.
What NCLEX-style question pattern comes up for hemochromatosis?
Expect questions asking you to identify phlebotomy as the correct treatment over iron chelation for most patients, recognise the bronze skin, diabetes, cirrhosis triad as a single disease process, and counsel against vitamin C or iron supplementation. Questions may also test genetic inheritance knowledge, since the autosomal recessive pattern is a common distractor point.
Should family members of a hemochromatosis patient be tested?
Yes. First-degree relatives should be offered screening with serum ferritin and transferrin saturation, since hereditary hemochromatosis is autosomal recessive and siblings in particular have a meaningful chance of also carrying two copies of the mutated gene. Early identification allows treatment before organ damage develops.
More on med-surg